Literature DB >> 20972600

Comparison of composite disease activity indices for rheumatoid arthritis.

Toshihiro Matsui1, Yoshiaki Kuga, Jinju Nishino, Atsushi Kaneko, Yoshito Eto, Shigeto Tohma.   

Abstract

To evaluate the composite disease activity indices for rheumatoid arthritis (RA), we compared disease activities and the changes therein calculated using the Disease Activity Score based on 28 joint counts using erythrocyte sedimentation rate (DAS28-ESR), DAS28-CRP (C-reactive protein), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index (CDAI) in a cohort of 1,412 patients with RA. The median (1st; 3rd quartile) scores were 4.20 (3.31; 5.14) for DAS28-ESR, 3.44 (2.59; 4.36) for DAS28-CRP, 13.6 (7.49; 21.1) for SDAI, and 12.0 (6.9; 18.9) for CDAI. Absolute scores and their changes were significantly correlated (p < 0.0001) in all combinations among these four disease activity indices; however, their correlations were lower in males than in females. Correlations between disease activity indices and the clinical and acute phase reactant variables were different according to disease activity index, sex and age. A comparison of the number of patients in each disease activity category according to the disease activity indices using kappa-statistics revealed an almost perfect agreement between SDAI and CDAI (κ = 0.871), a moderate agreement between DAS28-ESR and SDAI (κ = 0.415) or CDAI (κ = 0.427), but only fair agreement between DAS28-ESR and DAS28-CRP (κ = 0.329). For the selection of a disease activity index for an evaluation of RA patients, both the convenience and the characteristics of the respective disease activity index should be considered.

Entities:  

Mesh:

Year:  2010        PMID: 20972600     DOI: 10.1007/s10165-010-0367-6

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis.

Authors:  Emmanuel Ruiz-Medrano; Hector Fabricio Espinosa-Ortega; Cesar Alejandro Arce-Salinas
Journal:  Clin Rheumatol       Date:  2019-05-10       Impact factor: 2.980

2.  Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis.

Authors:  Li-Ming Pu; Yin Liu; De-Xin Zhou; Xi-Jia Tang; Chao-Nan Fan; Wen Chen; Jian-da Ma; Jian-Zi Lin; Lie Dai; Li Ling
Journal:  Clin Rheumatol       Date:  2022-08-10       Impact factor: 3.650

Review 3.  Targeting interleukin-6 in rheumatoid arthritis.

Authors:  Md Yuzaiful Md Yusof; Paul Emery
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.